Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

5.9K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
5.9K
Anatomy of the Eyeball01:20

Anatomy of the Eyeball

6.5K
The eye is a spherical, hollow structure composed of three tissue layers. The outer layer — the fibrous tunic, comprises the sclera — a white structure — and the cornea, which is transparent. The sclera encompasses some of the ocular surface, most of which is not visible. However, the 'white of the eye' is distinctively visible in humans compared to other species. The cornea, a clear covering at the front of the eye, enables light penetration. The eye's middle...
6.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Six-Month Real-World Data in Macular Edema Due to Retinal Vein Occlusion Treated with Faricimab: Swiss Retina Research Network Report.

Ophthalmology and therapy·2026
Same author

Parafoveal Dark Adaptation in Early and Intermediate Age-Related Macular Degeneration.

Investigative ophthalmology & visual science·2026
Same author

Microvascular Properties of Dissociated Optic Nerve Fiber Layer (DONFL) After Internal Limiting Membrane Peeling.

Investigative ophthalmology & visual science·2026
Same author

The Therapeutic Approach and Mechanism of Action of Insulin Eye Drops for the Treatment of Neurotrophic Keratitis.

Drug design, development and therapy·2026
Same author

The optical coherence tomography and microperimetry biomarker evaluation in patients with geographic atrophy (OMEGA) study: Geographic atrophy progression in fundus autofluorescence - OMEGA report 3.

Acta ophthalmologica·2026
Same author

Twelve-Month Outcomes Using Aflibercept 8 mg in Treatment-Naïve and Pretreated Diabetic Macular Edema: A Swiss Retina Research Network Report.

Ophthalmology science·2026
Same journal

Corneal Neurotisation in Neurotrophic Keratopathy: A Retrospective Analysis of Functional Outcomes and Clinical Courses.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Evaluating the Long-term Success and Safety of Canaloplasty in Glaucoma Patients.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Imbalanced Trace Elements as Risk Factors in the Pathogenesis of Glaucoma.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Malnutrition as a Risk Factor for Cerebral and Glaucomatous Neurodegeneration - Mechanisms and Therapeutic Strategies.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Impact of Wearing a Face Mask on the Reliability of Standard Automated Perimetry in Glaucoma Patients and Suspects: a Retrospective Longitudinal Study.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

[Siderotic Cataract Eight Months After Intralenticular Metallic Foreign Body: A Case Report and Surgical Management].

Klinische Monatsblatter fur Augenheilkunde·2026
See all related articles

Related Experiment Video

Updated: Jun 12, 2025

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability
07:23

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability

Published on: August 6, 2021

2.6K

[Retinal Vein Occlusions].

Nicolas Feltgen, Kristina Pfau, Josep Callizo

    Klinische Monatsblatter Fur Augenheilkunde
    |December 6, 2024
    PubMed
    Summary
    This summary is machine-generated.

    Retinal vein occlusion requires individual risk assessment, including screening for glaucoma and systemic vascular issues. Treatment options involve intravitreal medications or laser therapy for retinal anomalies.

    More Related Videos

    In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility
    07:35

    In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility

    Published on: April 21, 2022

    2.1K
    Application of Optical Coherence Tomography to a Mouse Model of Retinopathy
    08:22

    Application of Optical Coherence Tomography to a Mouse Model of Retinopathy

    Published on: January 12, 2022

    4.0K

    Related Experiment Videos

    Last Updated: Jun 12, 2025

    Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability
    07:23

    Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability

    Published on: August 6, 2021

    2.6K
    In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility
    07:35

    In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility

    Published on: April 21, 2022

    2.1K
    Application of Optical Coherence Tomography to a Mouse Model of Retinopathy
    08:22

    Application of Optical Coherence Tomography to a Mouse Model of Retinopathy

    Published on: January 12, 2022

    4.0K

    Area of Science:

    • Ophthalmology
    • Vascular Medicine
    • Systemic Diseases

    Background:

    • Retinal vein occlusion (RVO) is a complex condition with systemic implications.
    • Identifying individual risk profiles is crucial for effective management.
    • Ocular hypertension and glaucoma are potential co-existing conditions.

    Purpose of the Study:

    • To emphasize the importance of comprehensive risk assessment in RVO patients.
    • To highlight the need for screening systemic vascular risk factors.
    • To outline current therapeutic strategies for retinal anomalies associated with RVO.

    Main Methods:

    • Clinical evaluation for glaucoma and ocular hypertension.
    • Systemic screening for vascular diseases and risk factors.
    • Review of treatment modalities including intravitreal injections and laser therapy.

    Main Results:

    • Individualized risk profiling is essential for RVO management.
    • Systemic vascular health assessment is a key component of patient care.
    • Multiple treatment options exist for retinal anomalies.

    Conclusions:

    • Ophthalmologists must systematically rule out glaucoma and ocular hypertension.
    • Screening for systemic vascular risk factors is paramount in RVO patients.
    • Treatment decisions for RVO should be tailored based on individual patient profiles and available therapeutic options.